Mutalik S, Udupa N
College of Pharmaceutical Sciences, Manipal, India.
Pharmazie. 2002 Dec;57(12):838-41.
The purpose of this investigation was to study the feasibility of transdermal delivery of glibenclamide and glipizide. In vitro permeation of these drugs was studied through mouse skin using various penetration enhancers like Tween -20, polyethyleneglycol-400, ethanol and d-limonene by simultaneous application of drug and enhancer solution or by pretreatment of the skin with neat enhancer. The partition coefficient values indicated that both drugs partition well into the skin. Glipizide did not show any skin metabolism, while glibenclamide showed a minimal metabolism during in vitro skin metabolism studies. The flux values (microgram/cm2/h) of both drugs significantly (p < 0.05) increased in the presence of penetration enhancers. The glibenclamide flux values ranged from 1.39 +/- 0.13 without enhancer, to 19.01 +/- 2.14 in a combination of 50% ethanol and 5% d-limonene. Glipizide flux values ranged from 3.01 +/- 0.74 without enhancer, to 62.97 +/- 7.10 in a combination of 50% ethanol and 5% d-limonene. Skin retention and solubility of both drugs increased with all penetration enhancers compared to control. The target permeation rates for glibenclamide and glipizide were calculated to be 193.8 and 184.8 micrograms/h respectively. The present study showed that the target permeation rates for both drugs could be achieved with the aid of enhancers by increasing the area of application in an appreciable range.
本研究的目的是探讨格列本脲和格列吡嗪经皮给药的可行性。通过同时应用药物和增强剂溶液或用纯增强剂预处理皮肤,使用吐温 -20、聚乙二醇 -400、乙醇和d-柠檬烯等各种渗透促进剂,研究了这些药物在小鼠皮肤中的体外渗透情况。分配系数值表明两种药物均能很好地分配到皮肤中。在体外皮肤代谢研究中,格列吡嗪未表现出任何皮肤代谢,而格列本脲表现出极少的代谢。在渗透促进剂存在下,两种药物的通量值(微克/平方厘米/小时)均显著增加(p < 0.05)。格列本脲的通量值范围从无增强剂时的1.39±0.13,到50%乙醇和5% d-柠檬烯组合时的19.01±2.14。格列吡嗪的通量值范围从无增强剂时的3.01±0.74,到50%乙醇和5% d-柠檬烯组合时的62.97±7.10。与对照组相比,所有渗透促进剂均使两种药物的皮肤滞留量和溶解度增加。计算得出格列本脲和格列吡嗪的目标渗透速率分别为193.8和184.8微克/小时。本研究表明,借助增强剂,通过在相当大的范围内增加给药面积,可以实现两种药物的目标渗透速率。